You can always take the meizitang slimforte products in your handbags

In order to resolve the potential channel conflict. Abbott diet pills ~ a “marketing strategy Conclusion With China’s rapid economic development, the Chinese people’s living standards improve, obesity is becoming an increasingly serious health problems, which formed a huge potential weight loss drug market. The world’s leading pharmaceutical companies – Abbott intends to diet pills …. “The introduction of the Chinese market, it is first approved by the FDA, the efficacy of weight loss western medicine. Generics today’s weight loss drug market is already facing fierce competition. People can also eat meizitang in their offices. You can always take the meizitang slimforte products in your handbags.The reform of the appearance of the box, colors, and specifications suitable for the Chinese constitution and dose; 1) products to provide customers with Good after-sales service. 2) the price reasonable price is 375 – 337 yuan / month; supplemented by cash discounts, seasonal discounts, quantity discounts, and other methods to build a flexible price system. 3) promoting the holding of public relations activities, the formation of expert advisory group, the pharmacist and manager training, word of mouth mechanism, listed on trial, etc. 4) the channel used mainly the production of 11 medical units, retail pharmacies, pharmacy chain mode, near the residence of the well-known drugstore chain distribution in the focus.
If you don’t want to spend much, you can trymeizitang for a month as a trial.The structural transformation of the weight-loss drug rimonabant.
But in Asia there is a new problem, namely the problem of obesity in the level of a lower BMI than Westerners related diseases which may be deposited in the abdomen caused by the Asian fat, so the 2000 WHO specifically for the Asian developed a new obesity diagnostic criteria (Table 2). table an Asian adult BMI criteria and related disease risk classification weight is too low normal range, overweight in BMI (kg/m2) <18.5-related disease risk is low (but risk of other diseases increase) increase in average 18.5 ~~ 22.9 ≥ 23 with mild obesity, severe obesity 25 ~~ 29.9 ≥ 30 moderate increase significantly increase. Like almost every industry in China, meizitang is also having mass production.
Source: WHO obesity treatment guidelines, although total body fat mass is very important, but more importantly, the distribution of fat men often see the accumulation of visceral fat in the abdomen, known as the central obesity; female fat distribution in the hip and thigh, known as peripheral obesity on the health hazards caused by abdominal fat than the fat of the buttocks or other parts of the [6] in 1998, the WHO recommends the preferred waist to measure abdominal fat, the waist 94cm of men and women Waist 80cm for European populations, indicators of abdominal obesity for Asians. Themeizitangmedication treatment supplements the lack of ways of curing obesity.